LUNG Pulmonx Corporation

$1.85▲ +0.00% Healthcare Other
After hours $1.85▲ +0.00% Sep 11, 7:30 PM ET
Volume 204.9K Avg Volume (10D) 354.1K
Key Metrics & Fundamentals
Market Cap
$79.45M
P/E Ratio
–
Div Yield
–%
52W Range
1.13 - 2.89
% vs 50 MA
-1.07%
% vs 200 MA
9.60%
RSI-14
37.8
MACD Histogram
-0.0900
Beta (1Y vs SPY)
2.25
Free Cash Flow
-$5.22M
Gross Rev
$22.76M
Gross Profit
$17.74M
EBITDA
-$8.51M
COGS
$5.01M
Operating Exp
$26.80M
Operating Income
-$9.06M
EBIT
-$9.06M
Pretax Income
-$9.95M
Net Income
-$10.08M
EPS (Diluted)
-0.24
Price & Volume History
Loading chart…
Recent News
Pulmonx Shares Fall Following Recent Gains
InvestorsHub · Sep 3, 2026 12:28 PM
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 1, 2026 8:05 PM
Pulmonx to Participate in Upcoming Investor Conferences
GlobeNewswire · Aug 27, 2026 8:05 PM
Pulmonx Corporation (LUNG) Now Trades Above Golden Cross: Time to Buy?
Zacks · Aug 26, 2026 1:55 PM
Pulmonx Rebuilds Sales Force, Targets Growth and AeriSeal Launch Next Year
MarketBeat · Aug 15, 2026 6:01 AM
What Makes Pulmonx Corporation (LUNG) a Strong Momentum Stock: Buy Now?
Zacks · Aug 14, 2026 4:00 PM
Pulmonx (LUNG) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 8, 2026 1:02 AM
Pulmonx (LUNG) Upgraded to Buy: What Does It Mean for the Stock?
Zacks · Aug 3, 2026 4:00 PM
Pulmonx Corporation Q2 2026 Earnings Call Summary
Moby · Jul 30, 2026 12:30 PM
Pulmonx Q2 Earnings Call Highlights
MarketBeat · Jul 29, 2026 11:04 PM
Financial Overview - Income Statement Quarterly

See LUNG's money flow as a full page

Social Sentiment
Avg +0.62 · 32 posts
NewsEarningsPriceTargetIOVA 🚀
r/wallstreetbets · Aug 7, 2026
The post highlights the positive lung study data as a catalyst for growth, creating bullish sentiment.
positive +0.70
NewsDiscussionCurious If Anyone Has Thoughts on IBRX (ImmunityBio)
r/stocks · Aug 7, 2026
The author highlights the approval of IBRX for LUNG cancer treatment and potential for further applications.
positive +0.40
NewsTrade(IBRX) another banger after my last banger call
r/stocks · Jul 30, 2026
While not a direct stock mention, ‘LUNG’ refers to a specific ongoing trial conducted by Immunity Bio – indicating a positive focus on the company's research and development.
positive +0.60
NewsWhy I invested $900k in IOVa
r/stocks · Jul 11, 2026
The post highlights the potential success of LUNG's clinical trial results as a significant factor in IOVA's stock price.
positive +0.80
NewsDiscussionBNTX ASCO 2026 DD
r/wallstreetbets · May 31, 2026
Discussion of Keytruda’s market share and BioNTech's ambition to compete.
positive +0.60
Page 1 of 7 (32 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙